Boundless Bio (BOLD) IPO deck
Boundless Bio is a pioneering company focused on understanding and treating challenging cancers, particularly those driven by oncogene amplifications.
Boundless Bio is a pioneering company focused on understanding and treating challenging cancers, particularly those driven by oncogene amplifications.
%20IPO%20deck){kind=link}